CME
CME Group Inc. NASDAQ$289.54
After hrs
$288.96
-0.46%
Mkt Cap $104.3B
52w Low $257.17
45.0% of range
52w High $329.16
50d MA $303.36
200d MA $281.56
P/E (TTM)
25.9x
EV/EBITDA
17.1x
P/B
3.6x
Debt/Equity
0.1x
ROE
15.3%
P/FCF
23.4x
RSI (14)
—
ATR (14)
—
Beta
0.30
50d MA
$303.36
200d MA
$281.56
Avg Volume
2.4M
About
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settli…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | AMC | 3.34 | 3.36 | +0.6% | 285.71 | -0.2% | -0.1% | -0.2% | -1.3% | -0.4% | +0.5% | — | — |
| Feb 4, 2026 | AMC | 2.75 | 2.77 | +0.7% | 294.62 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% | +7.6% | — |
| Oct 22, 2025 | AMC | 2.63 | 2.68 | +1.9% | 267.81 | +1.9% | +0.4% | +0.6% | +1.2% | -0.6% | -2.3% | +2.0% | — |
| Jul 23, 2025 | AMC | 2.91 | 2.96 | +1.7% | 276.48 | -0.0% | +0.3% | +1.1% | -0.9% | -0.7% | +0.5% | -2.5% | — |
| Apr 23, 2025 | AMC | 2.80 | 2.80 | +0.0% | 261.48 | +0.0% | +0.7% | +1.8% | +2.5% | +4.2% | +6.0% | +8.6% | — |
| Feb 12, 2025 | AMC | 2.46 | 2.52 | +2.4% | 248.96 | +0.6% | +0.5% | -1.4% | -0.4% | +0.7% | -0.3% | +3.9% | — |
| Oct 23, 2024 | AMC | 2.66 | 2.68 | +0.8% | 227.14 | -0.2% | +1.1% | -0.4% | +0.4% | -0.0% | +0.1% | +0.8% | — |
| Jul 24, 2024 | AMC | 2.53 | 2.56 | +1.2% | 197.25 | +0.1% | +1.1% | +1.7% | +0.8% | -0.0% | -1.8% | +5.0% | — |
| Apr 24, 2024 | AMC | 2.45 | 2.50 | +2.0% | 212.59 | -0.1% | -0.0% | -0.8% | -1.4% | -1.4% | -2.1% | +1.1% | — |
| Feb 14, 2024 | AMC | 2.28 | 2.37 | +3.9% | 215.18 | -0.4% | -1.9% | -1.4% | -1.9% | -0.1% | +1.3% | +1.1% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 | Morgan Stanley | Maintains | Overweight → Overweight | — | $285.71 | $285.11 | -0.2% | -0.1% | -0.2% | -1.3% | -0.4% | +0.5% |
| Apr 23 | Barclays | Maintains | Equal Weight → Equal Weight | — | $285.71 | $285.11 | -0.2% | -0.1% | -0.2% | -1.3% | -0.4% | +0.5% |
| Apr 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $297.03 | $296.89 | -0.0% | -0.0% | -0.3% | -3.2% | -3.2% | -4.3% |
| Apr 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $295.30 | $297.12 | +0.6% | +1.8% | +0.6% | +0.5% | +0.3% | -2.6% |
| Apr 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $298.93 | $300.86 | +0.6% | -1.2% | +0.6% | -0.6% | -0.7% | -0.9% |
| Apr 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $310.58 | $299.36 | -3.6% | -2.5% | -3.8% | -4.9% | -3.2% | -4.4% |
| Mar 4 | Argus | Downgrade | Buy → Hold | — | $325.13 | $319.82 | -1.6% | -1.6% | -2.6% | -2.5% | -1.9% | -5.8% |
| Feb 5 | JP Morgan | Maintains | Underweight → Underweight | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Feb 5 | Barclays | Maintains | Equal Weight → Equal Weight | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
| Feb 5 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $294.62 | $297.00 | +0.8% | +0.9% | +2.6% | +4.3% | +4.1% | +2.7% |
Recent Filings
8-K
CME Group Inc. -- 8-K Filing
CME Group must maintain compliance with a consolidated tangible net worth test under its existing 364-day credit facility, a standard covenant protecting lenders against financial deterioration.
Apr 27
8-K
CME Group Inc. -- 8-K Filing
CME Group disclosed non-GAAP financial measures in its earnings report, providing reconciliations to GAAP equivalents for investor comparison and transparency.
Apr 22
8-K
CME Group Inc. -- 8-K Filing
CME Group disclosed non-GAAP financial measures in its 8-K filing with reconciliations to GAAP equivalents, allowing investors to evaluate performance using both adjusted and standard accounting metrics.
Feb 4
8-K · 7.01
! Medium
CME Group Inc. -- 8-K 7.01: Regulation FD Disclosure
CME Group notified clients of pricing changes through a special executive report, indicating potential adjustments to its fee structure that could affect trading costs for market participants.
Feb 2
Data updated apr 25, 2026 1:57am
· Source: massive.com